nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—chronic obstructive pulmonary disease	0.721	1	CbGaD
Gatifloxacin—ALB—Prednisone—chronic obstructive pulmonary disease	0.0363	1	CbGbCtD
Gatifloxacin—Pefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00118	0.184	CrCbGaD
Gatifloxacin—Enoxacin—CYP1A2—chronic obstructive pulmonary disease	0.00111	0.172	CrCbGaD
Gatifloxacin—Lomefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000838	0.13	CrCbGaD
Gatifloxacin—Levofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000716	0.111	CrCbGaD
Gatifloxacin—Ofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000716	0.111	CrCbGaD
Gatifloxacin—Ciprofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000691	0.108	CrCbGaD
Gatifloxacin—Norfloxacin—CYP1A1—chronic obstructive pulmonary disease	0.000602	0.0936	CrCbGaD
Gatifloxacin—Norfloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000581	0.0903	CrCbGaD
Gatifloxacin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00162	CcSEcCtD
Gatifloxacin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.00162	CcSEcCtD
Gatifloxacin—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00038	0.00161	CcSEcCtD
Gatifloxacin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000377	0.0016	CcSEcCtD
Gatifloxacin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000375	0.00159	CcSEcCtD
Gatifloxacin—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00158	CcSEcCtD
Gatifloxacin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00158	CcSEcCtD
Gatifloxacin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00158	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00037	0.00157	CcSEcCtD
Gatifloxacin—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00155	CcSEcCtD
Gatifloxacin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00155	CcSEcCtD
Gatifloxacin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000365	0.00155	CcSEcCtD
Gatifloxacin—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00154	CcSEcCtD
Gatifloxacin—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00154	CcSEcCtD
Gatifloxacin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00154	CcSEcCtD
Gatifloxacin—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.00036	0.00153	CcSEcCtD
Gatifloxacin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000359	0.00152	CcSEcCtD
Gatifloxacin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00152	CcSEcCtD
Gatifloxacin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00152	CcSEcCtD
Gatifloxacin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00152	CcSEcCtD
Gatifloxacin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00152	CcSEcCtD
Gatifloxacin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00152	CcSEcCtD
Gatifloxacin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00152	CcSEcCtD
Gatifloxacin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00152	CcSEcCtD
Gatifloxacin—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00152	CcSEcCtD
Gatifloxacin—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00152	CcSEcCtD
Gatifloxacin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00152	CcSEcCtD
Gatifloxacin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00152	CcSEcCtD
Gatifloxacin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00152	CcSEcCtD
Gatifloxacin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00151	CcSEcCtD
Gatifloxacin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00149	CcSEcCtD
Gatifloxacin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000352	0.00149	CcSEcCtD
Gatifloxacin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000352	0.00149	CcSEcCtD
Gatifloxacin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00149	CcSEcCtD
Gatifloxacin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00148	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000349	0.00148	CcSEcCtD
Gatifloxacin—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.00147	CcSEcCtD
Gatifloxacin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00146	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00146	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00146	CcSEcCtD
Gatifloxacin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00146	CcSEcCtD
Gatifloxacin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00146	CcSEcCtD
Gatifloxacin—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000343	0.00146	CcSEcCtD
Gatifloxacin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00145	CcSEcCtD
Gatifloxacin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00145	CcSEcCtD
Gatifloxacin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00144	CcSEcCtD
Gatifloxacin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00144	CcSEcCtD
Gatifloxacin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00144	CcSEcCtD
Gatifloxacin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.00144	CcSEcCtD
Gatifloxacin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00143	CcSEcCtD
Gatifloxacin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00143	CcSEcCtD
Gatifloxacin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00143	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00143	CcSEcCtD
Gatifloxacin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00142	CcSEcCtD
Gatifloxacin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00142	CcSEcCtD
Gatifloxacin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00142	CcSEcCtD
Gatifloxacin—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00142	CcSEcCtD
Gatifloxacin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00141	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00033	0.0014	CcSEcCtD
Gatifloxacin—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00138	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00138	CcSEcCtD
Gatifloxacin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00138	CcSEcCtD
Gatifloxacin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00137	CcSEcCtD
Gatifloxacin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00136	CcSEcCtD
Gatifloxacin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00136	CcSEcCtD
Gatifloxacin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00136	CcSEcCtD
Gatifloxacin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00032	0.00136	CcSEcCtD
Gatifloxacin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00136	CcSEcCtD
Gatifloxacin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00134	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000317	0.00134	CcSEcCtD
Gatifloxacin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00133	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00133	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000314	0.00133	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.00133	CcSEcCtD
Gatifloxacin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00132	CcSEcCtD
Gatifloxacin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00132	CcSEcCtD
Gatifloxacin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00131	CcSEcCtD
Gatifloxacin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00131	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000307	0.0013	CcSEcCtD
Gatifloxacin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.0013	CcSEcCtD
Gatifloxacin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000307	0.0013	CcSEcCtD
Gatifloxacin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.0013	CcSEcCtD
Gatifloxacin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000306	0.0013	CcSEcCtD
Gatifloxacin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00129	CcSEcCtD
Gatifloxacin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00129	CcSEcCtD
Gatifloxacin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00128	CcSEcCtD
Gatifloxacin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00128	CcSEcCtD
Gatifloxacin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00128	CcSEcCtD
Gatifloxacin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000302	0.00128	CcSEcCtD
Gatifloxacin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00127	CcSEcCtD
Gatifloxacin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000299	0.00127	CcSEcCtD
Gatifloxacin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00126	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00126	CcSEcCtD
Gatifloxacin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00125	CcSEcCtD
Gatifloxacin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00125	CcSEcCtD
Gatifloxacin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00125	CcSEcCtD
Gatifloxacin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00124	CcSEcCtD
Gatifloxacin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00123	CcSEcCtD
Gatifloxacin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00122	CcSEcCtD
Gatifloxacin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000287	0.00122	CcSEcCtD
Gatifloxacin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00121	CcSEcCtD
Gatifloxacin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00121	CcSEcCtD
Gatifloxacin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00121	CcSEcCtD
Gatifloxacin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.0012	CcSEcCtD
Gatifloxacin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000284	0.0012	CcSEcCtD
Gatifloxacin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.0012	CcSEcCtD
Gatifloxacin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.0012	CcSEcCtD
Gatifloxacin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.0012	CcSEcCtD
Gatifloxacin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000282	0.0012	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00119	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00119	CcSEcCtD
Gatifloxacin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00118	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00117	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00117	CcSEcCtD
Gatifloxacin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00116	CcSEcCtD
Gatifloxacin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00116	CcSEcCtD
Gatifloxacin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00115	CcSEcCtD
Gatifloxacin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00115	CcSEcCtD
Gatifloxacin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00115	CcSEcCtD
Gatifloxacin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00115	CcSEcCtD
Gatifloxacin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.00115	CcSEcCtD
Gatifloxacin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00114	CcSEcCtD
Gatifloxacin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00114	CcSEcCtD
Gatifloxacin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00114	CcSEcCtD
Gatifloxacin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00114	CcSEcCtD
Gatifloxacin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00114	CcSEcCtD
Gatifloxacin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00114	CcSEcCtD
Gatifloxacin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.00113	CcSEcCtD
Gatifloxacin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.00113	CcSEcCtD
Gatifloxacin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00113	CcSEcCtD
Gatifloxacin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00113	CcSEcCtD
Gatifloxacin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00113	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00113	CcSEcCtD
Gatifloxacin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00109	CcSEcCtD
Gatifloxacin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00109	CcSEcCtD
Gatifloxacin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00109	CcSEcCtD
Gatifloxacin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00108	CcSEcCtD
Gatifloxacin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00108	CcSEcCtD
Gatifloxacin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00107	CcSEcCtD
Gatifloxacin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00107	CcSEcCtD
Gatifloxacin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00107	CcSEcCtD
Gatifloxacin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00105	CcSEcCtD
Gatifloxacin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00105	CcSEcCtD
Gatifloxacin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00105	CcSEcCtD
Gatifloxacin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00103	CcSEcCtD
Gatifloxacin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00103	CcSEcCtD
Gatifloxacin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00103	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00103	CcSEcCtD
Gatifloxacin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00103	CcSEcCtD
Gatifloxacin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00102	CcSEcCtD
Gatifloxacin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00101	CcSEcCtD
Gatifloxacin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.000998	CcSEcCtD
Gatifloxacin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000235	0.000998	CcSEcCtD
Gatifloxacin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00099	CcSEcCtD
Gatifloxacin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.000989	CcSEcCtD
Gatifloxacin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000231	0.000978	CcSEcCtD
Gatifloxacin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.000975	CcSEcCtD
Gatifloxacin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.000968	CcSEcCtD
Gatifloxacin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000228	0.000965	CcSEcCtD
Gatifloxacin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.000965	CcSEcCtD
Gatifloxacin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000223	0.000945	CcSEcCtD
Gatifloxacin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000944	CcSEcCtD
Gatifloxacin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.000943	CcSEcCtD
Gatifloxacin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000219	0.000928	CcSEcCtD
Gatifloxacin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.000928	CcSEcCtD
Gatifloxacin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00092	CcSEcCtD
Gatifloxacin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00092	CcSEcCtD
Gatifloxacin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000919	CcSEcCtD
Gatifloxacin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000919	CcSEcCtD
Gatifloxacin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000914	CcSEcCtD
Gatifloxacin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000914	CcSEcCtD
Gatifloxacin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000913	CcSEcCtD
Gatifloxacin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.000911	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000911	CcSEcCtD
Gatifloxacin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000214	0.000909	CcSEcCtD
Gatifloxacin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000901	CcSEcCtD
Gatifloxacin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000212	0.0009	CcSEcCtD
Gatifloxacin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000211	0.000895	CcSEcCtD
Gatifloxacin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000885	CcSEcCtD
Gatifloxacin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.000876	CcSEcCtD
Gatifloxacin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.00087	CcSEcCtD
Gatifloxacin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000869	CcSEcCtD
Gatifloxacin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000868	CcSEcCtD
Gatifloxacin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000868	CcSEcCtD
Gatifloxacin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000204	0.000867	CcSEcCtD
Gatifloxacin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.000867	CcSEcCtD
Gatifloxacin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000863	CcSEcCtD
Gatifloxacin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000851	CcSEcCtD
Gatifloxacin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0002	0.000849	CcSEcCtD
Gatifloxacin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000839	CcSEcCtD
Gatifloxacin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000836	CcSEcCtD
Gatifloxacin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000823	CcSEcCtD
Gatifloxacin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.000818	CcSEcCtD
Gatifloxacin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000804	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00079	CcSEcCtD
Gatifloxacin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00079	CcSEcCtD
Gatifloxacin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.000778	CcSEcCtD
Gatifloxacin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000771	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000764	CcSEcCtD
Gatifloxacin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000755	CcSEcCtD
Gatifloxacin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000715	CcSEcCtD
Gatifloxacin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00071	CcSEcCtD
Gatifloxacin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000704	CcSEcCtD
Gatifloxacin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000663	CcSEcCtD
Gatifloxacin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000651	CcSEcCtD
Gatifloxacin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000647	CcSEcCtD
Gatifloxacin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000643	CcSEcCtD
Gatifloxacin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000632	CcSEcCtD
Gatifloxacin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000631	CcSEcCtD
Gatifloxacin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000628	CcSEcCtD
Gatifloxacin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000618	CcSEcCtD
Gatifloxacin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00061	CcSEcCtD
Gatifloxacin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000608	CcSEcCtD
Gatifloxacin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000599	CcSEcCtD
Gatifloxacin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000599	CcSEcCtD
Gatifloxacin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000597	CcSEcCtD
Gatifloxacin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000582	CcSEcCtD
Gatifloxacin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000574	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000574	CcSEcCtD
Gatifloxacin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000571	CcSEcCtD
Gatifloxacin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000565	CcSEcCtD
Gatifloxacin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000561	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000555	CcSEcCtD
Gatifloxacin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000547	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000523	CcSEcCtD
Gatifloxacin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000523	CcSEcCtD
Gatifloxacin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000519	CcSEcCtD
Gatifloxacin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000516	CcSEcCtD
Gatifloxacin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000506	CcSEcCtD
Gatifloxacin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000499	CcSEcCtD
Gatifloxacin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000498	CcSEcCtD
Gatifloxacin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000498	CcSEcCtD
Gatifloxacin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000495	CcSEcCtD
Gatifloxacin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000491	CcSEcCtD
Gatifloxacin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000473	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00047	CcSEcCtD
Gatifloxacin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000469	CcSEcCtD
Gatifloxacin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000456	CcSEcCtD
Gatifloxacin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000454	CcSEcCtD
Gatifloxacin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000454	CcSEcCtD
Gatifloxacin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.98e-05	0.000423	CcSEcCtD
Gatifloxacin—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000412	CcSEcCtD
Gatifloxacin—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.000406	CcSEcCtD
Gatifloxacin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.27e-05	0.000393	CcSEcCtD
Gatifloxacin—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.00038	CcSEcCtD
Gatifloxacin—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.61e-05	0.000365	CcSEcCtD
Gatifloxacin—Rash—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.000362	CcSEcCtD
Gatifloxacin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000362	CcSEcCtD
Gatifloxacin—Headache—Prednisone—chronic obstructive pulmonary disease	8.48e-05	0.00036	CcSEcCtD
Gatifloxacin—Nausea—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000341	CcSEcCtD
